| 摘要 |
<p>The invention discloses a virally modified tumour-specific vaccine consisting of corresponding separated tumour cells inactivated by radiation and incubated with NDV virus under sterile conditions in a serum-free medium. The vaccine may be irradiated again before application.</p> |
